Maas Tanja, Nieuwhof Chris, Passos Valeria Lima, Robertson Caroline, Boonen Annelies, Landewé Robert B, Voncken J Willem, Knottnerus J André, Damoiseaux Jan G
Department of General Practice, Maastricht University, CAPHRI, Maastricht, The Netherlands.
Prim Care Respir J. 2014 Mar;23(1):14-21. doi: 10.4104/pcrj.2013.00108.
Corresponding with the T helper cell type 1/T helper cell type 2 hypothesis, autoimmune and allergic diseases are considered pathologically distinct and mutually exclusive conditions. Co-occurrence of autoimmune disorders and allergy within patients, however, has been reported. Transgenerational co-occurrence of autoimmune and allergic disease has been less often described and may differ from the intra-patient results.
To test the hypothesis that autoimmune disorders in parents are a risk factor for the development of an allergic disease in their offspring.
Prospectively registered (by academic general practitioners) International Classifications of Primary Care (ICPC) for diagnoses of autoimmune disorders and allergy within families were evaluated (n=5,604 families) by performing multiple logistic regression analyses.
The presence of any ICPC-encoded autoimmune disorder in fathers appeared to be associated with an increased risk in their eldest children of developing an allergy (odds ratio (OR) 1.4, 95% CI 1.042 to 1.794). Psoriasis in fathers was particularly shown to be of influence (OR 1.5, 95% CI 1.061 to 2.117) and, although any ICPC-encoded autoimmune disease in mothers was found not to be of significance, the combined international code for registering rheumatoid arthritis/ankylosing spondylitis in mothers was OR 1.7 (95% CI 1.031 to 2.852).
The occurrence of ICPC-encoded autoimmune disorders in parents, especially psoriasis and rheumatoid arthritis/ankylosing spondylitis, significantly increases the occurrence of allergic disease in their children. After validation in follow-up research in a larger sample, these results may lead to the inclusion of 'parental autoimmune condition' as a risk factor in the general practitioner's diagnostics of allergic disease.
与1型辅助性T细胞/2型辅助性T细胞假说相一致,自身免疫性疾病和过敏性疾病在病理上被认为是截然不同且相互排斥的病症。然而,已有报道称患者体内会同时出现自身免疫性疾病和过敏症状。自身免疫性疾病和过敏性疾病的跨代共同出现情况较少被描述,可能与患者个体内的结果有所不同。
检验父母的自身免疫性疾病是其后代发生过敏性疾病的危险因素这一假说。
通过进行多项逻辑回归分析,对前瞻性登记(由学术全科医生进行)的国际初级保健分类(ICPC)中家庭内自身免疫性疾病和过敏症的诊断情况进行评估(n = 5604个家庭)。
父亲患有任何ICPC编码的自身免疫性疾病似乎与其长子患过敏症的风险增加有关(比值比(OR)为1.4,95%置信区间为1.042至1.794)。特别显示父亲患银屑病有影响(OR为1.5,95%置信区间为1.061至2.117),虽然发现母亲患有任何ICPC编码的自身免疫性疾病无显著意义,但母亲类风湿关节炎/强直性脊柱炎的联合国际编码的OR为1.7(95%置信区间为1.031至2.852)。
父母患有ICPC编码的自身免疫性疾病,尤其是银屑病和类风湿关节炎/强直性脊柱炎,会显著增加其子女患过敏性疾病的几率。在更大样本的后续研究中得到验证后,这些结果可能会导致“父母自身免疫状况”被纳入全科医生诊断过敏性疾病的危险因素中。